White Pine Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
White Pine Capital's GILD Position: Q3 2026 in Review
White Pine Capital increased its Gilead Sciences (GILD) stake by 0.07% in Q3 2026, buying an estimated $281 and bringing the position to 3,056 shares worth $455K. The position accounts for 0.11% of the portfolio, ranked #183.
White Pine Capital first reported a position in GILD in Q4 2024 and has held it in 8 quarters since. 2,355 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- White Pine Capital held 3,056 shares of Gilead Sciences worth $455K as of Q3 2026.
- White Pine Capital bought 2 Gilead Sciences shares in Q3 2026, an estimated $281.
- Gilead Sciences made up 0.11% of White Pine Capital's portfolio in Q3 2026, its #183 holding.
- White Pine Capital first reported a position in Gilead Sciences in Q4 2024 and has held it in 8 quarters since.
- 2,355 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on White Pine Capital's 13F filing for Q3 2026, filed 9 Nov 2026.